Cargando…
Protection of Mice from Acute Graft-versus-Host Disease Requires CD28 Co-stimulation on Donor CD4(+) Foxp3(+) Regulatory T Cells
Acute graft-versus-host disease (aGvHD) is a major cause of morbidity and mortality after allogeneic hematopoietic stem cell plus T cell transplantation (allo-HSCT). In this study, we investigated the requirement for CD28 co-stimulation of donor CD4(+) conventional (CD4(+)CD25(−)Foxp3(−), Tconv) and...
Autores principales: | Uri, Anna, Werner, Sandra, Lühder, Fred, Hünig, Thomas, Kerkau, Thomas, Beyersdorf, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481316/ https://www.ncbi.nlm.nih.gov/pubmed/28690612 http://dx.doi.org/10.3389/fimmu.2017.00721 |
Ejemplares similares
-
CD28 co-stimulation in T-cell homeostasis: a recent perspective
por: Beyersdorf, Niklas, et al.
Publicado: (2015) -
CD28 Costimulation of T Helper 1 Cells Enhances Cytokine Release In Vivo
por: Langenhorst, Daniela, et al.
Publicado: (2018) -
Hsp90 inhibition ameliorates CD4(+) T cell‐mediated acute Graft versus Host disease in mice
por: Berges, Carsten, et al.
Publicado: (2016) -
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis
por: Beyersdorf, Niklas, et al.
Publicado: (2005) -
Topological Requirements and Signaling Properties of T Cell–activating, Anti-CD28 Antibody Superagonists
por: Lühder, Fred, et al.
Publicado: (2003)